Welcome to The MedTech Forum 2021

The platform is closed.
Thank you for your participation in the MedTech Forum 2021.


Catherine ABI-HABIB



Company Group Chairman
Johnson & Johnson Medical Devices Companies Europe, Middle East & Africa (EMEA)


Senior Vice President
Abbott Core Diagnostics

Bassil AKRA


Catherine is a partner in McKinsey's London office and a leader in McKinsey's Pharmaceutical and Medical Products practice. 

She focuses on delivering large scale digital and analytics enabled transformations. Her recent work includes global, cross business unit, customer experience and go-to-market model transformations. She works closely with clients to build the capabilities and change programmes to enable lasting change and performance improvements. 

Catherine holds an MSc in Economics from the London School of Economics and a BA in Mathematics from the University of Cambridge.


Hani Abouhalka is the Company Group Chairman for Johnson & Johnson (J&J) Medical Devices Companies, the world's largest and most comprehensive medical technology business. He is responsible for the company's Medical Device businesses in Europe, Middle East & Africa (EMEA), which includes surgical technology, orthopaedics, cardiovascular and specialty solutions directed at delivering clinical and economic value to healthcare systems.

A purpose-driven and global leader, Hani brings with him an outstanding 20-year record of driving transformational growth across EMEA's developed and emerging markets, building high-performing teams and championing Johnson & Johnson values.

Throughout his career, Hani has held several leadership roles of increasing responsibility across multiple disciplines (business and strategy development, health economics, operations, and management roles), businesses (Medical Devices, Ethicon, Biosurgery, and Cordis) and geographies, from the US to Lebanon and the UAE to the Benelux region and the UK. Before being appointed to his current role in December 2018, Hani served as Vice President, Medical Devices Strategy Development & Global Operations, focused on advancing the process and execution of the global business strategy, improving portfolio value and implementing critical capabilities.

Known for putting the needs of patients first, Hani is passionate about strengthening Johnson & Johnson's footprint in key markets and advancing diverse talent across the enterprise. He is also committed to shaping sustainable solutions that positively impact the health of millions of people.

Hani is the executive sponsor of the Women's Leadership & Inclusion employee resource group in EMEA, which supports the advancement of gender equality at J&J. He also serves as Board Member of the Johnson & Johnson Foundation, a registered charity responsible for managing J&J's Global Community Impact programs and activities across EMEA.

Hani holds a Bachelor's degree in Biology from Arizona State University and a Master's degree in International Business from Thunderbird, The Garvin School of International Management.


Greg Ahlberg is Senior Vice President, Core Laboratory Diagnostics, Commercial Operations. He was appoiinted to his role in October 2020.

Prior to assuming his current position, Greg served as Vice President, General Manager Commercial Operations EMEA.

Greg joined Abbott in 1988 in the Financial Professional Development Program. Greg has served this business across varying roles in finance. manufaturing, and commercial operations throughout his Abbott career, contributing to our company's success in the U.S., Latin Amercian and Asia.

Greg earned a B. Sc. in Finance from Indiana University and an M.B.A. from Kellogg School of Management, Northwestern University.

Dr. Bassil Akra is the CEO and co-owner of QUNIQUE GmbH, a medical device and in-vitro diagnostic consultancy company, located in Germany and Switzerland. He spent the last decade as a subject matter expert at the biggest notified body in Europe and represented locally and the globally the notified body association in the various European discussion. Dr. Akra was the Vice President for strategic business development at the Global Medical Health Services of TÜV SÜD Product Service GmbH in Germany. He has long experience in leadership, business management, research, development, quality management and regulatory approval of medical devices, combination devices and ATMP products. Dr. Akra played an essential role during the implementation of the medical device regulation (MDR 2017/745) in Europe and was involved in the drafting of the several European guidance documents (e.g. MEDDEV, MDCG, etc.). He spent the last years of his career at TÜV SÜD training and educating the various stakeholders on the EU Legislations (e.g. MDD/AIMDD, MDR and IVDR) and their impact on the EU healthcare system.

See all